Results 101 to 110 of about 53,162 (283)
Association of HBsAg levels with differential gene expression in NK, CD8 T, and memory B cells in treated patients with chronic HBV [PDF]
Boris J. B. Beudeker +8 more
openalex +1 more source
ABSTRACT Hepatitis D virus (HDV) screening rates in the United States are low. We evaluated the impact of double reflex‐based HDV testing on HDV‐related morbidity and mortality in the United States. A Screen and Treat model simulated the HDV screening cascade (decision tree) and assessed the natural history of HDV (Markov model) over a 5‐year time ...
Robert J. Wong +8 more
wiley +1 more source
ABSTRACT Accurate estimates of the prevalence of chronic hepatitis B virus (HBV) in the United States (US) are necessary for policy makers and community‐based organisations to make informed decisions regarding the allocation of resources to work towards the elimination of HBV as a public health threat.
Devin Razavi‐Shearer +11 more
wiley +1 more source
Survey of both hepatitis B virus (HBsAg) and hepatitis C virus (HCV-Ab) coinfection among HIV positive patients [PDF]
Mohsen Mohammadi +6 more
openalex +1 more source
Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays.
Hepatitis B surface antigen (HBsAg) is considered the best marker for the diagnosis of hepatitis B virus (HBV) infection. Mutations of the s gene involving amino acid substitutions within the a determinant could affect the sensitivity of diagnostic tests.
Veropalumbo E. +12 more
openaire +5 more sources
What's New? Liver function decreases with age, affecting the metabolism of many chemotherapy drugs. For older cancer patients, however, a standardized liver status screening method is lacking. Here, Fibrosis‐4 (FIB‐4) score was investigated for its utility as a non‐invasive method in predicting treatment toxicity and mortality in cancer patients age 70
Victoire de Salins +14 more
wiley +1 more source
Purpose: Hepatitis B virus (HBV) infection is a global public health problem with significant morbidity and mortality rates and the detection of HBsAg is a very important test for diagnosis.
Melek Bilgin +3 more
doaj +1 more source
This study employed tRNASUAG, an anticodon‐engineered tRNA (ACE‐tRNA), to introduce a phosphorylatable serine into the C‐terminal domain of HBc by reading through its stop codon, thereby potentially promoting the ubiquitin‐proteasome degradation of HBc, and subsequently inhibiting HBV replication. Through a tRNASUAG‐gHBV1‐tRNASUAG‐gHBV2‐tRNASUAG tandem
Xingwen Yang +7 more
wiley +1 more source

